Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
Published
02/25/2021 at 5:15 am
Downloads
1
Related Resources
ASTA Comments to FDA on Allergen Thresholds
Positions & Comments
Allergens & Other Food Safety Issues
5/1/2013
ASTA issued comments to the Food and Drug Administration (FDA) in May 2013 regarding allergen thresholds, advocating for FDA's role to protect public health and the food supply by adopting allergen policies based on sound science and thoughtful policy.
NCFIA Comments Regarding FDA/CBP Coordination on Prior Notice Requirements
Positions & Comments
Allergens & Other Food Safety Issues
5/11/2004
NCFIA issued comments to the Food and Drug Administration in May 2004 regarding joint FDA and Customs and Border Protection plans for increasing integration and assessing the coordination of prior notice timeframes.